Kim Monkhorst
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
-
- Lung Cancer Treatments and Mutations
- Occupational and environmental lung diseases
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 52
- Lung Cancer Diagnosis and Treatment 14
- Occupational and environmental lung diseases 11
- Oncology 65
- Cancer Immunotherapy and Biomarkers 25
- Colorectal Cancer Treatments and Studies 17
- CAR-T cell therapy research 11
- Lung Cancer Research Studies 10
- Co-authors
- Paul Baas (13 shared papers)Vincent van der Noort (20 shared papers)Ferry Lalezari (9 shared papers)Jeltje F. de Vries (6 shared papers)Joost Gribnau (7 shared papers)Adrianus J. de Langen (9 shared papers)Egbert F. Smit (34 shared papers)Willemijn S.M.E. Theelen (12 shared papers)
- Journals
- Journal of Thoracic Oncology (13 papers)Annals of Oncology (8 papers)Journal of Clinical Oncology (7 papers)Clinical Cancer Research (5 papers)Lung Cancer (5 papers)
- Partner nations
- NetherlandsUnited StatesSwitzerland
In The Last Decade
Kim Monkhorst
103 papers receiving 3.4k citations
Kim Monkhorst's Hit Papers
Peers
Comparison fields: 5 of 95
- Oncology 1.8k
- Pulmonary and Respiratory Medicine 1.5k
- Cancer Research 665
- Immunology 455
- Genetics 429
Countries citing papers authored by Kim Monkhorst
This map shows the geographic impact of Kim Monkhorst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Monkhorst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Monkhorst more than expected).
Fields of papers citing papers by Kim Monkhorst
This network shows the impact of papers produced by Kim Monkhorst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Monkhorst. The network helps show where Kim Monkhorst may publish in the future.
Co-authors
The 25 scholars most cited alongside Kim Monkhorst, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 112 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non–Small Cell Lung Cancer Hit paper breakdown → | 2019 | 651 |
| 2 | An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer Hit paper breakdown → | 2021 | 195 |
| 3 | 2009 | 182 | |
| 4 | 2018 | 167 | |
| 5 | 2020 | 164 | |
| 6 | 2019 | 159 | |
| 7 | 2016 | 156 | |
| 8 | 2008 | 126 | |
| 9 | 2016 | 106 | |
| 10 | 2017 | 77 | |
| 11 | 2019 | 63 | |
| 12 | 2008 | 62 | |
| 13 | 2019 | 60 | |
| 14 | 2018 | 55 | |
| 15 | 2020 | 54 | |
| 16 | 2018 | 47 | |
| 17 | 2020 | 41 | |
| 18 | 2005 | 41 | |
| 19 | 2018 | 40 | |
| 20 | 2010 | 40 |
About Kim Monkhorst
Kim Monkhorst is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Genetics, having authored 112 papers that have together received 3.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (52 papers), Cancer Genomics and Diagnostics (34 papers), Cancer Immunotherapy and Biomarkers (25 papers), Colorectal Cancer Treatments and Studies (17 papers), Lung Cancer Diagnosis and Treatment (14 papers), CAR-T cell therapy research (11 papers), Occupational and environmental lung diseases (11 papers) and Lung Cancer Research Studies (10 papers). The work is most often cited by research in Oncology (1.8k citations), Pulmonary and Respiratory Medicine (1.5k citations), Cancer Research (665 citations), Immunology (455 citations) and Genetics (429 citations). Kim Monkhorst has collaborated with scholars based in Netherlands, United States and Switzerland. Frequent co-authors include Paul Baas, Vincent van der Noort, Ferry Lalezari, Jeltje F. de Vries, Joost Gribnau, Adrianus J. de Langen, Egbert F. Smit, Willemijn S.M.E. Theelen, Iris H. Jonkers and Joachim G.J.V. Aerts. Their work appears in journals such as Journal of Thoracic Oncology, Annals of Oncology, Journal of Clinical Oncology, Clinical Cancer Research and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.